Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta‐analysis

Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta‐analysis provides a...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Movement disorders Ročník 35; číslo 1; s. 45 - 54
Hlavní autori: Baiano, Chiara, Barone, Paolo, Trojano, Luigi, Santangelo, Gabriella
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Hoboken, USA John Wiley & Sons, Inc 01.01.2020
Wiley Subscription Services, Inc
Predmet:
Age Factors
Clinical aspects
Cognitive ability
cognitive decline
Cognitive Dysfunction - complications
Cognitive Dysfunction - epidemiology
Confidence intervals
Dementia disorders
Emotional behavior
Gait
Humans
Levodopa
Meta-analysis
Mild cognitive impairment
Movement disorders
Neurodegenerative diseases
Neuropsychological Tests
nonmotor symptoms
Parkinson Disease - complications
Parkinson Disease - enzymology
Parkinson's disease
Prevalence
Quality of life
Risk Factors
prevalence
Parkinson's disease
cognitive decline
Mild cognitive impairment
nonmotor symptoms
ISSN:0885-3185, 1531-8257, 1531-8257
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta‐analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and s, 41 studies were selected (n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36–44; Q = 490.14, P < 0.0001; I2 = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23–41, Q = 93.24; P < 0.0001; I2 = 92.49%). Meta‐regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta‐analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society
AbstractList Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta‐analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and abstracts, 41 studies were selected (n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36–44; Q = 490.14, P < 0.0001; I2 = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23–41, Q = 93.24; P < 0.0001; I2 = 92.49%). Meta‐regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta‐analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta‐analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and s, 41 studies were selected (n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36–44; Q = 490.14, P < 0.0001; I2 = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23–41, Q = 93.24; P < 0.0001; I2 = 92.49%). Meta‐regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta‐analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta-analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and abstracts, 41 studies were selected (n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36-44; Q = 490.14, P < 0.0001; I = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23-41, Q = 93.24; P < 0.0001; I = 92.49%). Meta-regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta-analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society.
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta‐analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and abstracts, 41 studies were selected ( n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36–44; Q = 490.14, P < 0.0001; I 2 = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23–41, Q = 93.24; P < 0.0001; I 2 = 92.49%). Meta‐regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta‐analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society
Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta-analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and abstracts, 41 studies were selected (n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36-44; Q = 490.14, P < 0.0001; I2 = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23-41, Q = 93.24; P < 0.0001; I2 = 92.49%). Meta-regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta-analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society.Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early identification of mild cognitive impairment in PD, its prevalence and clinical correlates are still debated. The present meta-analysis provides a robust estimate of prevalence rate of mild cognitive impairment in PD according to the Movement Disorder Society clinical criteria and to explore the differences between PD patients with and without mild cognitive impairment in demographic, clinical, and neuropsychiatric features. A systematic literature search was performed up to April 2019 using PsycInfo (PROQUEST), PubMed, and Scopus. From 4706 titles and abstracts, 41 studies were selected (n = 7053 patients). Pooled mild cognitive impairment prevalence was 40% on a total sample of 7053 PD patients (95% confidence interval = 36-44; Q = 490.14, P < 0.0001; I2 = 91.84%) with a higher frequency for the multiple domain subtype (31%; 95% confidence interval = 23-41, Q = 93.24; P < 0.0001; I2 = 92.49%). Meta-regression analysis revealed that stage of PD moderate prevalence estimates of mild cognitive impairment (β = 2.80; P = 0.008). Mild cognitive impairment in PD was associated with older age, lower education, longer disease duration, higher levodopa equivalent daily dose, more severe motor symptoms, and postural instability/gait difficulty motor subtype, poorer quality of life, higher levels of apathy, and depression. The present meta-analysis indicated that mild cognitive impairment in PD is a frequent cognitive status deserving to be early detected by means of standardized cognitive assessments in clinical practice. © 2019 International Parkinson and Movement Disorder Society.
Author Santangelo, Gabriella
Baiano, Chiara
Barone, Paolo
Trojano, Luigi
Author_xml – sequence: 1
  givenname: Chiara
  surname: Baiano
  fullname: Baiano, Chiara
  organization: University of Campania Luigi Vanvitelli
– sequence: 2
  givenname: Paolo
  surname: Barone
  fullname: Barone, Paolo
  organization: University of Salerno
– sequence: 3
  givenname: Luigi
  surname: Trojano
  fullname: Trojano, Luigi
  organization: University of Campania Luigi Vanvitelli
– sequence: 4
  givenname: Gabriella
  orcidid: 0000-0002-7728-852X
  surname: Santangelo
  fullname: Santangelo, Gabriella
  email: gabriella.santangelo@unicampania.it
  organization: University of Campania Luigi Vanvitelli
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31743500$$D View this record in MEDLINE/PubMed
BookMark eNp10c1OFTEYBuDGYOTws_AGTBMXymKgP9MzHXcEBUwgkCjr5pvOV1PstMd2DubsvASv0Sth4Bw2BFdd9HnfNH13yFZMEQl5y9khZ0wcDX05FE3LxCsy40rySgvVbJEZ01pVkmu1TXZKuWWMc8Xnb8i25E0tFWMz4q4z3kHAaJFC7KkNPnoLgUJZoB0LTY4OPkwX6Uf0o79D6ocF-DxgHKmP9BryTx9Lih8K7X1BKPiJHtMBR_j35y9ECKviyx557SAU3N-cu-Tm9Mv3k_Pq4urs68nxRWVr3ooK0GpZa9HYBl0HrdbO1SgV7-pOcux5D1pb1s1b4FI5VKJ27RxbCbIBcFLuko_r3kVOv5ZYRjP4YjEEiJiWxQjJ57Vo65ZP9P0zepuWeXrvg5qMaqRWk3q3UctuwN4ssh8gr8zTD07gaA1sTqVkdMb6EUaf4pjBB8OZedjITBuZx42mxMGzxFPpS3bT_tsHXP0fmsvP39aJe9muoUU
CitedBy_id crossref_primary_10_3390_jcm12144594
crossref_primary_10_1109_TNSRE_2024_3431234
crossref_primary_10_7759_cureus_47549
crossref_primary_10_1007_s11011_022_00937_2
crossref_primary_10_1016_j_jep_2022_115502
crossref_primary_10_1016_j_jns_2020_116861
crossref_primary_10_1111_ene_15818
crossref_primary_10_1155_padi_6870215
crossref_primary_10_1186_s12883_024_03920_9
crossref_primary_10_1002_pri_2140
crossref_primary_10_1002_brb3_3440
crossref_primary_10_1016_j_neurot_2025_e00561
crossref_primary_10_1038_s41531_024_00687_1
crossref_primary_10_3389_fnagi_2022_788846
crossref_primary_10_3389_frsle_2023_1302021
crossref_primary_10_3389_fneur_2024_1403105
crossref_primary_10_1002_mds_70005
crossref_primary_10_1080_23279095_2024_2356658
crossref_primary_10_1007_s40520_023_02493_w
crossref_primary_10_1038_s41531_023_00619_5
crossref_primary_10_3233_JPD_240092
crossref_primary_10_3389_fnagi_2022_896191
crossref_primary_10_1080_13854046_2025_2450020
crossref_primary_10_4103_1673_5374_301026
crossref_primary_10_1097_PXT_0000000000000010
crossref_primary_10_1038_s41440_021_00704_3
crossref_primary_10_1186_s12883_021_02426_y
crossref_primary_10_1159_000545937
crossref_primary_10_1371_journal_pone_0276218
crossref_primary_10_1007_s10072_021_05772_4
crossref_primary_10_1111_cns_14789
crossref_primary_10_1155_2021_8360627
crossref_primary_10_1080_02703181_2024_2430221
crossref_primary_10_3389_fnins_2022_781488
crossref_primary_10_1016_j_neubiorev_2022_104749
crossref_primary_10_1007_s10286_021_00841_2
crossref_primary_10_3389_fnins_2021_781722
crossref_primary_10_3390_brainsci12070923
crossref_primary_10_3390_neurolint16020032
crossref_primary_10_1186_s40035_023_00341_5
crossref_primary_10_1016_j_jns_2021_120015
crossref_primary_10_1007_s10072_024_07778_0
crossref_primary_10_3390_bs14020101
crossref_primary_10_1002_brb3_3345
crossref_primary_10_3389_fnins_2023_1278817
crossref_primary_10_55735_d8fhqy58
crossref_primary_10_1016_j_parkreldis_2021_09_018
crossref_primary_10_1093_cercor_bhab313
crossref_primary_10_3390_ijms241713294
crossref_primary_10_3389_fnagi_2022_914049
crossref_primary_10_1093_braincomms_fcaf029
crossref_primary_10_1007_s13760_024_02710_x
crossref_primary_10_1016_j_neulet_2023_137219
crossref_primary_10_1080_13854046_2025_2461750
crossref_primary_10_1097_HRP_0000000000000283
crossref_primary_10_1159_000547180
crossref_primary_10_1002_acn3_51429
crossref_primary_10_1002_ana_26927
crossref_primary_10_1016_j_parkreldis_2024_106987
crossref_primary_10_1016_j_prdoa_2025_100365
crossref_primary_10_3390_ijms25010498
crossref_primary_10_1016_j_neulet_2020_135034
crossref_primary_10_1038_s41392_024_02020_x
crossref_primary_10_3389_fnana_2025_1566835
crossref_primary_10_1007_s00415_021_10519_4
crossref_primary_10_1080_13854046_2022_2157885
crossref_primary_10_1002_mdc3_70080
crossref_primary_10_3389_fnins_2024_1360935
crossref_primary_10_1007_s11682_021_00471_2
crossref_primary_10_1177_08919887231225484
crossref_primary_10_3233_JPD_212812
crossref_primary_10_3389_fnagi_2022_1003595
crossref_primary_10_1111_jnp_12307
crossref_primary_10_1007_s13760_022_02078_w
crossref_primary_10_1016_j_jns_2025_123507
crossref_primary_10_1080_14737175_2025_2450668
crossref_primary_10_1002_dad2_70091
crossref_primary_10_1016_j_jep_2023_117623
crossref_primary_10_1007_s11682_024_00872_z
crossref_primary_10_1038_s41572_021_00280_3
crossref_primary_10_1080_13607863_2020_1839860
crossref_primary_10_1097_MRR_0000000000000596
crossref_primary_10_1186_s12974_023_02843_5
crossref_primary_10_1007_s40520_024_02922_4
crossref_primary_10_1089_g4h_2022_0120
crossref_primary_10_1007_s10489_022_04276_8
crossref_primary_10_1007_s10072_024_07803_2
crossref_primary_10_5498_wjp_v13_i7_478
crossref_primary_10_3389_fnagi_2022_783634
crossref_primary_10_3390_brainsci14040305
crossref_primary_10_1007_s00521_023_08489_x
crossref_primary_10_1038_s41531_025_00958_5
crossref_primary_10_31083_j_jin2302025
crossref_primary_10_1016_j_arcmed_2024_103086
crossref_primary_10_1016_j_revmed_2020_06_019
crossref_primary_10_1038_s41531_022_00316_9
crossref_primary_10_1002_alz_13836
crossref_primary_10_1017_S1355617720000909
crossref_primary_10_1155_2020_8983960
crossref_primary_10_1016_j_jns_2024_123091
crossref_primary_10_2147_NDT_S358150
crossref_primary_10_2147_NDT_S509510
crossref_primary_10_1002_mds_29502
crossref_primary_10_3389_fnagi_2022_781480
crossref_primary_10_1016_j_parkreldis_2025_107300
crossref_primary_10_1016_j_phrs_2025_107732
crossref_primary_10_3389_fneur_2022_1010147
crossref_primary_10_3389_fnagi_2022_832768
crossref_primary_10_1002_ajim_23685
crossref_primary_10_3233_JAD_220058
crossref_primary_10_3389_fnagi_2021_745438
crossref_primary_10_1016_j_jvoice_2024_12_001
crossref_primary_10_1007_s11055_025_01820_0
crossref_primary_10_1093_brain_awac007
crossref_primary_10_1177_08919887231154933
crossref_primary_10_3389_fneur_2025_1434733
crossref_primary_10_3390_nu17030391
crossref_primary_10_3892_ijmm_2025_5546
crossref_primary_10_3389_fnagi_2022_943438
crossref_primary_10_1186_s10020_021_00301_7
crossref_primary_10_3389_fnins_2024_1495975
crossref_primary_10_1016_j_heliyon_2024_e27069
crossref_primary_10_1002_mds_29649
crossref_primary_10_1007_s10072_022_05985_1
crossref_primary_10_3390_s25020338
crossref_primary_10_1007_s11136_022_03187_y
crossref_primary_10_1007_s10072_024_07436_5
crossref_primary_10_1177_17562864251315137
crossref_primary_10_3390_jpm11050429
crossref_primary_10_1111_cts_70066
crossref_primary_10_3389_fnagi_2024_1434943
crossref_primary_10_3233_JPD_212688
crossref_primary_10_1002_brb3_2516
crossref_primary_10_1371_journal_pone_0275738
crossref_primary_10_1038_s41598_021_86483_w
crossref_primary_10_1016_j_mad_2023_111821
crossref_primary_10_1016_j_aggp_2025_100171
crossref_primary_10_2147_JIR_S342672
crossref_primary_10_1016_j_gerinurse_2022_05_003
crossref_primary_10_1007_s00415_024_12871_7
crossref_primary_10_3389_fnbeh_2025_1607421
crossref_primary_10_2147_IJGM_S399307
crossref_primary_10_3389_fpubh_2024_1436722
crossref_primary_10_3390_bs11050074
crossref_primary_10_1111_cns_14706
crossref_primary_10_1093_scan_nsae073
crossref_primary_10_36833_lkl_2022_021
crossref_primary_10_1002_ana_26903
crossref_primary_10_1136_bmjopen_2024_087164
crossref_primary_10_1007_s00415_025_13070_8
crossref_primary_10_1038_s41531_022_00416_6
crossref_primary_10_1007_s10072_022_06347_7
crossref_primary_10_1007_s42451_025_00795_z
crossref_primary_10_1007_s00415_024_12484_0
crossref_primary_10_1002_hbm_25606
crossref_primary_10_1007_s10072_022_06411_2
crossref_primary_10_1159_000532115
crossref_primary_10_3390_s23041985
crossref_primary_10_3389_fneur_2025_1628697
crossref_primary_10_3389_fnagi_2024_1465016
crossref_primary_10_1177_1545968321999053
crossref_primary_10_1016_j_arabjc_2023_104982
crossref_primary_10_1016_j_heliyon_2024_e31325
crossref_primary_10_1080_13803395_2023_2241653
crossref_primary_10_1007_s10072_021_05840_9
crossref_primary_10_3389_fnbeh_2022_951268
crossref_primary_10_3389_fnagi_2021_770528
crossref_primary_10_3389_fnsys_2021_777706
crossref_primary_10_2147_NSS_S375098
crossref_primary_10_3390_brainsci12010054
crossref_primary_10_3390_diagnostics13152482
crossref_primary_10_1186_s41983_022_00541_2
crossref_primary_10_1111_ane_13662
crossref_primary_10_1080_14737175_2023_2173576
crossref_primary_10_1097_MD_0000000000036420
crossref_primary_10_1016_j_parkreldis_2025_108001
crossref_primary_10_21733_ibad_1700404
crossref_primary_10_1016_j_parkreldis_2022_05_020
crossref_primary_10_1371_journal_pone_0262504
crossref_primary_10_3389_fpsyg_2022_1018176
crossref_primary_10_1142_S0192415X24500861
crossref_primary_10_1186_s12989_025_00622_z
crossref_primary_10_3390_jcm13133884
crossref_primary_10_3389_fneur_2024_1413187
crossref_primary_10_1016_j_yhbeh_2022_105206
crossref_primary_10_2147_NDT_S460938
crossref_primary_10_1080_17549507_2025_2541682
crossref_primary_10_1038_s41598_025_85118_8
crossref_primary_10_1080_13854046_2025_2503374
crossref_primary_10_1177_08919887251366638
crossref_primary_10_1007_s10072_025_08151_5
crossref_primary_10_1002_mdc3_14017
crossref_primary_10_1016_j_arr_2024_102200
crossref_primary_10_1007_s00221_025_07071_2
crossref_primary_10_1080_01616412_2023_2258038
crossref_primary_10_3389_fcogn_2024_1369538
crossref_primary_10_1038_s41598_024_79303_4
crossref_primary_10_3389_fnhum_2022_943472
crossref_primary_10_3233_JPD_202190
crossref_primary_10_1080_23279095_2021_2011727
crossref_primary_10_1038_s41598_022_15630_8
crossref_primary_10_1044_2024_AJSLP_24_00246
crossref_primary_10_3389_fnagi_2025_1620172
crossref_primary_10_1038_s41598_024_81787_z
crossref_primary_10_1007_s00415_024_12808_0
crossref_primary_10_1007_s10072_023_07071_6
crossref_primary_10_31083_j_jin2306110
crossref_primary_10_7717_peerj_15405
crossref_primary_10_1016_j_neubiorev_2021_04_003
crossref_primary_10_1002_acn3_52144
crossref_primary_10_1007_s10072_023_06740_w
crossref_primary_10_1186_s41155_023_00259_x
crossref_primary_10_3390_brainsci12010089
crossref_primary_10_3233_JPD_223314
Cites_doi 10.3174/ajnr.A4626
10.1016/j.parkreldis.2017.01.001
10.1016/j.neuropsychologia.2018.05.016
10.1159/000478849
10.3233/JPD-130189
10.1016/j.parkreldis.2018.02.007
10.1002/mds.24054
10.1136/bmj.315.7109.629
10.1002/hbm.23499
10.1002/mds.24893
10.1212/WNL.40.10.1529
10.1002/0470870168.ch8
10.3988/jcn.2018.14.1.16
10.1016/j.parkreldis.2014.07.004
10.1093/brain/awv211
10.1016/j.parkreldis.2018.04.015
10.1002/0470870168
10.1212/WNL.0000000000000066
10.1016/j.parkreldis.2017.08.003
10.1002/mds.25919
10.1016/j.jagp.2013.09.006
10.3174/ajnr.A4055
10.1159/000433421
10.1016/j.parkreldis.2014.10.020
10.1097/00007632-199510000-00009
10.7326/0003-4819-155-8-201110180-00009
10.1212/WNL.0b013e31829c5c86
10.1002/jmri.26548
10.1017/S1355617715000041
10.1016/j.neubiorev.2018.08.004
10.1002/hbm.22822
10.1002/mds.27002
10.1038/srep33929
10.1037/neu0000045
10.1080/13803395.2016.1207755
10.1212/WNL.0000000000003634
10.1159/000447533
10.3389/fnagi.2019.00021
10.1093/sleep/zsx101
10.1002/sim.1186
10.1002/mds.25655
10.1002/mds.25541
10.1212/WNL.0b013e3181f39d0e
10.1159/000350032
10.3389/fnhum.2016.00356
10.1002/mds.26643
10.1002/mds.25982
10.1176/appi.neuropsych.15090221
10.1016/j.parkreldis.2014.01.009
10.1111/pcn.12819
10.1016/j.parkreldis.2015.08.024
10.1177/0891988712464823
10.1016/j.jocn.2014.11.030
10.1212/01.wnl.0000180516.69442.95
10.1212/01.wnl.0000230572.07791.22
10.1002/brb3.719
10.1016/j.jns.2014.09.049
10.1016/j.parkreldis.2015.02.015
10.1007/s00415-018-8800-4
10.1002/gps.4261
10.1111/ene.13467
10.1177/1533317517698794
10.1002/mds.25426
10.1037/1082-989X.11.2.193
10.1111/j.1365-2796.2004.01388.x
10.1001/jamaneurol.2013.2110
10.1371/journal.pone.0152716
ContentType Journal Article
Copyright 2019 International Parkinson and Movement Disorder Society
2019 International Parkinson and Movement Disorder Society.
2020 International Parkinson and Movement Disorder Society
Copyright_xml – notice: 2019 International Parkinson and Movement Disorder Society
– notice: 2019 International Parkinson and Movement Disorder Society.
– notice: 2020 International Parkinson and Movement Disorder Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
DOI 10.1002/mds.27902
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Nursing & Allied Health Premium

MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8257
EndPage 54
ExternalDocumentID 31743500
10_1002_mds_27902
MDS27902
Genre reviewArticle
Meta-Analysis
Journal Article
Review
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3PY
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
K9.
NAPCQ
P64
RC3
7X8
ID FETCH-LOGICAL-c4192-aec834827c7efba988ff4e351b4b31ed1da88c0b69a135fe524f96e93a37aaf33
IEDL.DBID DRFUL
ISICitedReferencesCount 240
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000497131100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0885-3185
1531-8257
IngestDate Fri Jul 11 08:24:04 EDT 2025
Sat Nov 29 14:28:53 EST 2025
Wed Feb 19 02:29:45 EST 2025
Sat Nov 29 07:04:32 EST 2025
Tue Nov 18 20:57:48 EST 2025
Wed Jan 22 16:37:18 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords prevalence
Parkinson's disease
cognitive decline
Mild cognitive impairment
nonmotor symptoms
Language English
License 2019 International Parkinson and Movement Disorder Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4192-aec834827c7efba988ff4e351b4b31ed1da88c0b69a135fe524f96e93a37aaf33
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-7728-852X
PMID 31743500
PQID 2342957385
PQPubID 1016421
PageCount 10
ParticipantIDs proquest_miscellaneous_2316429491
proquest_journals_2342957385
pubmed_primary_31743500
crossref_citationtrail_10_1002_mds_27902
crossref_primary_10_1002_mds_27902
wiley_primary_10_1002_mds_27902_MDS27902
PublicationCentury 2000
PublicationDate January 2020
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: January 2020
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Movement disorders
PublicationTitleAlternate Mov Disord
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2017; 40
2017; 7
2015; 36
1997; 315
2013; 3
2013; 28
2019; 50
2019; 11
2017; 88
2015; 30
2017; 43
2016; 31
2005; 65
2013; 70
2014; 29
2014; 28
2016; 37
2011; 155
2014; 22
2014; 20
1990; 40
1995; 20
2003; 327
2004; 256
2006; 67
2015; 138
2017; 36
2015; 40
2017; 39
2017; 38
2017; 32
2016; 42
2014; 19
2012; 27
2012; 25
2014; 9
1988
2018; 265
2010; 75
2019; 73
2006; 11
2016; 10
2019; S1353‐8020
2005
2014; 82
2018; 25
2016; 11
2016; 6
2014; 347
2011; 102
2013; 36
2018; 118
2015; 22
2015; 21
2013; 81
2014; 35
2018; 50
2018; 94
2016; 28
2018; 54
2018; 14
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_68_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_66_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_64_1
e_1_2_8_62_1
e_1_2_8_41_1
e_1_2_8_60_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
Cohen J (e_1_2_8_21_1) 1988
e_1_2_8_38_1
e_1_2_8_57_1
Saredakis D (e_1_2_8_3_1) 2019; 1353
e_1_2_8_70_1
Goldman JG (e_1_2_8_59_1) 2011; 102
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_72_1
e_1_2_8_25_1
Chung EJ (e_1_2_8_29_1) 2014; 19
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_69_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_42_1
e_1_2_8_67_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_65_1
e_1_2_8_63_1
Wang Q (e_1_2_8_56_1) 2014; 9
e_1_2_8_40_1
e_1_2_8_61_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_58_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_52_1
e_1_2_8_73_1
e_1_2_8_50_1
e_1_2_8_71_1
References_xml – volume: 30
  start-page: 1048
  year: 2015
  end-page: 1055
  article-title: Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16‐year outcome evaluation of the Denbighshire cohort
  publication-title: Int J Geriatr Psychiatry
– volume: 29
  start-page: 1495
  year: 2014
  end-page: 1503
  article-title: Cortical thinning associated with mild cognitive impairment in Parkinson's disease
  publication-title: Mov Disord
– volume: 75
  start-page: 1062
  year: 2010
  end-page: 1069
  article-title: Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis
  publication-title: Neurology
– volume: 28
  start-page: 1360
  year: 2013
  end-page: 1369
  article-title: Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration
  publication-title: Mov Disord
– volume: 155
  start-page: 529
  year: 2011
  end-page: 536
  article-title: QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies
  publication-title: Ann Intern Med
– volume: 21
  start-page: 31
  year: 2015
  end-page: 35
  article-title: Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease
  publication-title: Parkinsonism Relat Disord
– year: 2005
– volume: 70
  start-page: 580
  year: 2013
  end-page: 586
  article-title: Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study
  publication-title: JAMA Neurol
– volume: 73
  start-page: 248
  year: 2019
  end-page: 253
  article-title: Global cognitive performance is associated with sleep efficiency measured by polysomnography in patients with Parkinson's disease
  publication-title: Psychiatry Clin Neurosci
– volume: 3
  start-page: 205
  year: 2013
  end-page: 214
  article-title: Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics
  publication-title: J Parkinsons Dis
– volume: 138
  start-page: 2974
  year: 2015
  end-page: 2986
  article-title: Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE‐PD study
  publication-title: Brain
– start-page: 11
  year: 2005
  end-page: 33
– volume: 6
  start-page: 33929
  year: 2016
  article-title: Prevalence and subtypes of mild cognitive impairment in Parkinson's disease
  publication-title: Sci Rep
– volume: S1353‐8020
  start-page: 30215
  issue: 19
  year: 2019
  end-page: 9
  article-title: Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta‐analysis
  publication-title: Parkinsonism Relat Disord
– volume: 19
  start-page: 19
  year: 2014
  end-page: 25
  article-title: Neuropsychological profiles and their correlation to motor symptoms in newly diagnosed Parkinson disease patients with mild cognitive impairment
  publication-title: Neurology Asia
– volume: 40
  start-page: 1529
  year: 1990
  end-page: 1534
  article-title: Variable expression of Parkinson's disease: a base‐line analysis of the DATATOP cohort. The Parkinson Study Group
  publication-title: Neurology
– volume: 42
  start-page: 17
  year: 2016
  end-page: 30
  article-title: Mild cognitive impairment in patients with early‐onset Parkinson's disease
  publication-title: Dement Geriatr Cogn Disord
– volume: 21
  start-page: 1219
  year: 2015
  end-page: 1226
  article-title: Mild cognitive impairment in newly diagnosed Parkinson's disease: a longitudinal prospective study
  publication-title: Parkinsonism Relat Disord
– volume: 50
  start-page: 183
  year: 2019
  end-page: 192
  article-title: Altered functional connectivity of the marginal division in Parkinson's disease with mild cognitive impairment: a pilot resting‐state fMRI study
  publication-title: J Magn Reson Imaging
– volume: 32
  start-page: 313
  year: 2017
  end-page: 319
  article-title: Accelerated age‐dependent hippocampal volume loss in Parkinson disease with mild cognitive impairment
  publication-title: Am J Alzheimers Dis Other Demen
– volume: 35
  start-page: 2257
  year: 2014
  end-page: 2264
  article-title: Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex‐based shape analysis
  publication-title: JNR Am J Neuroradiol
– volume: 82
  start-page: 308
  year: 2014
  end-page: 316
  article-title: Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE‐PD study
  publication-title: Neurology
– volume: 25
  start-page: 208
  year: 2012
  end-page: 214
  article-title: Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden
  publication-title: J Geriatr Psychiatry Neurol
– volume: 21
  start-page: 137
  year: 2015
  end-page: 145
  article-title: Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease
  publication-title: J Int Neuropsychol Soc
– volume: 65
  start-page: 1239
  year: 2005
  end-page: 1245
  article-title: Cognitive profile of patients with newly diagnosed Parkinson disease
  publication-title: Neurology
– volume: 54
  start-page: 62
  year: 2018
  end-page: 67
  article-title: Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: frequency and neuropsychological/neuropsychiatric correlates
  publication-title: Parkinsonism Relat Disord
– volume: 36
  start-page: 63
  year: 2017
  end-page: 68
  article-title: Anxiety is associated with cognitive impairment in newly‐diagnosed Parkinson's disease
  publication-title: Parkinsonism Relat Disord
– volume: 28
  start-page: 211
  year: 2016
  end-page: 216
  article-title: Mood differences among Parkinson's disease patients with mild cognitive impairment
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 28
  start-page: 229
  year: 2014
  end-page: 237
  article-title: Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment
  publication-title: Neuropsychology
– volume: 43
  start-page: 114
  year: 2017
  end-page: 117
  article-title: Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease
  publication-title: Parkinsonism Relat Disord
– volume: 67
  start-page: 33
  year: 2006
  end-page: 38
  article-title: Dissociating apathy and depression in Parkinson disease
  publication-title: Neurology
– volume: 7
  start-page: 297
  year: 2017
  end-page: 308
  article-title: Influence of mild cognitive impairment, depression, and anxiety on the quality of life of patients with Parkinson disease
  publication-title: Dement Geriatr Cogn Dis Extra
– volume: 20
  start-page: 1071
  year: 2014
  end-page: 1075
  article-title: Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
  publication-title: Parkinsonism Relat Disord
– volume: 347
  start-page: 210
  year: 2014
  end-page: 213
  article-title: Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment
  publication-title: J Neurol Sci
– volume: 11
  start-page: 0152716
  year: 2016
  article-title: Cerebral metabolic differences associated with cognitive impairment in Parkinson's disease
  publication-title: PLoS One
– volume: 315
  start-page: 629
  year: 1997
  end-page: 634
  article-title: Bias in meta‐analysis detected by a simple, graphical test
  publication-title: BMJ
– volume: 40
  start-page: 199
  year: 2015
  end-page: 209
  article-title: Mild cognitive impairment in early Parkinson's disease using the Movement Disorder Society Task Force Criteria: cross‐sectional study in Hoehn and Yahr stage 1
  publication-title: Dement Geriatr Cogn Disord
– volume: 36
  start-page: 2980
  year: 2015
  end-page: 2995
  article-title: Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease
  publication-title: Hum Brain Mapp
– volume: 256
  start-page: 183
  year: 2004
  end-page: 194
  article-title: Mild cognitive impairment as a diagnostic entity
  publication-title: J Intern Med
– volume: 28
  start-page: 626
  year: 2013
  end-page: 633
  article-title: Measuring mild cognitive impairment in patients with Parkinson's disease
  publication-title: Mov Disord
– volume: 22
  start-page: 981
  year: 2015
  end-page: 985
  article-title: A neurophysiological profile in Parkinson's disease with mild cognitive impairment and dementia in China
  publication-title: J Clin Neurosci
– volume: 28
  start-page: 1972
  year: 2013
  end-page: 1979
  article-title: Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease
  publication-title: Mov Disord
– volume: 94
  start-page: 1
  year: 2018
  end-page: 10
  article-title: “Pure apathy” and cognitive dysfunctions in Parkinson's disease: a meta‐analytic study
  publication-title: Neurosci Biobehav Rev
– volume: 14
  start-page: 16
  year: 2018
  end-page: 21
  article-title: Subjective cognitive complaints and objective cognitive impairment in Parkinson's disease
  publication-title: J Clin Neurol
– volume: 39
  start-page: 142
  year: 2017
  end-page: 162
  article-title: Contribution of four lifelong factors of cognitive reserve on late cognition in normal aging and Parkinson's disease
  publication-title: J Clin Exp Neuropsychol
– volume: 11
  start-page: 193
  year: 2006
  end-page: 206
  article-title: Assessing heterogeneity in meta‐analysis: Q statistic or I2 index?
  publication-title: Psychol Methods
– volume: 21
  start-page: 489
  year: 2015
  end-page: 493
  article-title: Apathy and striatal dopamine transporter levels in de‐novo, untreated Parkinson's disease patients
  publication-title: Parkinsonism Relat Disord
– volume: 22
  start-page: 1410
  year: 2014
  end-page: 1417
  article-title: Anxiety has specific syndromal profiles in Parkinson disease: a data‐driven approach
  publication-title: Am J Geriatr Psychiatry
– volume: 29
  start-page: 1035
  year: 2014
  end-page: 1043
  article-title: The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale
  publication-title: Mov Disord
– volume: 11
  start-page: 21
  year: 2019
  article-title: Incidence of mild cognitive impairment and dementia in Parkinson's disease: the Parkinson's Disease Cognitive Impairment Study
  publication-title: Front Aging Neurosci
– volume: 10
  start-page: 356
  year: 2016
  article-title: Subcortical volumes differ in Parkinson's disease motor subtypes: new insights into the pathophysiology of disparate symptoms
  publication-title: Front Hum Neurosci
– volume: 27
  start-page: 349
  year: 2012
  end-page: 356
  article-title: Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
  publication-title: Mov Disord
– volume: 20
  start-page: 394
  year: 2014
  end-page: 399
  article-title: Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia
  publication-title: Parkinsonism Relat Disord
– volume: 102
  start-page: 441
  year: 2011
  end-page: 459
  article-title: Mild cognitive impairment in Parkinson's disease
  publication-title: Minerva Med
– volume: 20
  start-page: 2112
  year: 1995
  end-page: 2118
  article-title: The prevalence of low back pain in the literature. A structured review of 26 Nordic studies from 1954 to 1993
  publication-title: Spine (Phila Pa 1976)
– volume: 9
  start-page: 275
  year: 2014
  end-page: 281
  article-title: Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors
  publication-title: Clin Interv Aging
– volume: 88
  start-page: 767
  year: 2017
  end-page: 774
  article-title: Natural course of mild cognitive impairment in Parkinson disease: a 5‐year population‐based study
  publication-title: Neurology
– volume: 327
  start-page: 557
  year: 2003
  end-page: 560
  article-title: Measuring inconsistency in meta‐analyses
  publication-title: BMJ
– volume: 27
  start-page: 480
  year: 2012
  end-page: 484
  article-title: Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool
  publication-title: Mov Disord
– volume: 81
  start-page: 346
  year: 2013
  end-page: 352
  article-title: Evolution of mild cognitive impairment in Parkinson disease
  publication-title: Neurology
– volume: 265
  start-page: 1050
  year: 2018
  end-page: 1058
  article-title: Mild cognitive impairment in Parkinson's disease: the Parkinson's Disease Cognitive Study (PACOS)
  publication-title: J Neurol
– year: 1988
– volume: 25
  start-page: 148
  year: 2018
  end-page: 153
  article-title: An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease
  publication-title: Eur J Neurol
– volume: 40
  issue: 8
  year: 2017
  article-title: REM sleep behavior disorder and cognitive impairment in Parkinson's disease
  publication-title: Sleep
– volume: 38
  start-page: 1702
  year: 2017
  end-page: 1715
  article-title: Intra‐ and inter‐network functional alterations in Parkinson's disease with mild cognitive impairment
  publication-title: Hum Brain Mapp
– volume: 118
  start-page: 4
  year: 2018
  end-page: 11
  article-title: Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation
  publication-title: Neuropsychologia
– volume: 7
  start-page: 00719
  year: 2017
  article-title: Associations between cognitive impairment and motor dysfunction in Parkinson's disease
  publication-title: Brain Behav
– volume: 50
  start-page: 29
  year: 2018
  end-page: 36
  article-title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
  publication-title: Parkinsonism Relat Disord
– volume: 37
  start-page: 897
  year: 2016
  end-page: 903
  article-title: Different functional and microstructural changes depending on duration of mild cognitive impairment in Parkinson disease
  publication-title: AJNR Am J Neuroradiol
– volume: 36
  start-page: 67
  year: 2013
  end-page: 75
  article-title: Impact of mild cognitive impairment on health‐related quality of life in Parkinson's disease
  publication-title: Dement Geriatr Cogn Disord
– volume: 31
  start-page: 1125
  year: 2016
  end-page: 1133
  article-title: Prevalence of anxiety in Parkinson's disease: a systematic review and meta‐analysis
  publication-title: Mov Disord
– volume: 32
  start-page: 1056
  year: 2017
  end-page: 1065
  article-title: Mild cognitive impairment as a risk factor for Parkinson's disease dementia
  publication-title: Mov Disord
– ident: e_1_2_8_50_1
  doi: 10.3174/ajnr.A4626
– ident: e_1_2_8_71_1
  doi: 10.1016/j.parkreldis.2017.01.001
– ident: e_1_2_8_9_1
  doi: 10.1016/j.neuropsychologia.2018.05.016
– ident: e_1_2_8_57_1
  doi: 10.1159/000478849
– ident: e_1_2_8_28_1
  doi: 10.3233/JPD-130189
– ident: e_1_2_8_64_1
  doi: 10.1016/j.parkreldis.2018.02.007
– ident: e_1_2_8_18_1
  doi: 10.1002/mds.24054
– ident: e_1_2_8_25_1
  doi: 10.1136/bmj.315.7109.629
– ident: e_1_2_8_44_1
  doi: 10.1002/hbm.23499
– volume: 102
  start-page: 441
  year: 2011
  ident: e_1_2_8_59_1
  article-title: Mild cognitive impairment in Parkinson's disease
  publication-title: Minerva Med
– ident: e_1_2_8_8_1
  doi: 10.1002/mds.24893
– ident: e_1_2_8_14_1
  doi: 10.1212/WNL.40.10.1529
– ident: e_1_2_8_26_1
  doi: 10.1002/0470870168.ch8
– ident: e_1_2_8_32_1
  doi: 10.3988/jcn.2018.14.1.16
– ident: e_1_2_8_34_1
  doi: 10.1016/j.parkreldis.2014.07.004
– ident: e_1_2_8_39_1
  doi: 10.1093/brain/awv211
– volume-title: Statistical Power Analysis for the Behavioral Sciences
  year: 1988
  ident: e_1_2_8_21_1
– ident: e_1_2_8_13_1
  doi: 10.1016/j.parkreldis.2018.04.015
– ident: e_1_2_8_24_1
  doi: 10.1002/0470870168
– ident: e_1_2_8_58_1
  doi: 10.1212/WNL.0000000000000066
– ident: e_1_2_8_72_1
  doi: 10.1016/j.parkreldis.2017.08.003
– ident: e_1_2_8_70_1
  doi: 10.1002/mds.25919
– ident: e_1_2_8_69_1
  doi: 10.1016/j.jagp.2013.09.006
– ident: e_1_2_8_38_1
  doi: 10.3174/ajnr.A4055
– ident: e_1_2_8_52_1
  doi: 10.1159/000433421
– ident: e_1_2_8_53_1
  doi: 10.1016/j.parkreldis.2014.10.020
– ident: e_1_2_8_17_1
  doi: 10.1097/00007632-199510000-00009
– ident: e_1_2_8_20_1
  doi: 10.7326/0003-4819-155-8-201110180-00009
– ident: e_1_2_8_27_1
  doi: 10.1212/WNL.0b013e31829c5c86
– ident: e_1_2_8_36_1
  doi: 10.1002/jmri.26548
– ident: e_1_2_8_37_1
  doi: 10.1017/S1355617715000041
– ident: e_1_2_8_67_1
  doi: 10.1016/j.neubiorev.2018.08.004
– volume: 9
  start-page: 275
  year: 2014
  ident: e_1_2_8_56_1
  article-title: Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors
  publication-title: Clin Interv Aging
– ident: e_1_2_8_45_1
  doi: 10.1002/hbm.22822
– volume: 1353
  start-page: 30215
  issue: 19
  year: 2019
  ident: e_1_2_8_3_1
  article-title: Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta‐analysis
  publication-title: Parkinsonism Relat Disord
– ident: e_1_2_8_2_1
  doi: 10.1002/mds.27002
– ident: e_1_2_8_33_1
  doi: 10.1038/srep33929
– ident: e_1_2_8_46_1
  doi: 10.1037/neu0000045
– ident: e_1_2_8_65_1
  doi: 10.1080/13803395.2016.1207755
– ident: e_1_2_8_43_1
  doi: 10.1212/WNL.0000000000003634
– ident: e_1_2_8_49_1
  doi: 10.1159/000447533
– ident: e_1_2_8_6_1
  doi: 10.3389/fnagi.2019.00021
– ident: e_1_2_8_73_1
  doi: 10.1093/sleep/zsx101
– ident: e_1_2_8_23_1
  doi: 10.1002/sim.1186
– ident: e_1_2_8_30_1
  doi: 10.1002/mds.25655
– ident: e_1_2_8_63_1
  doi: 10.1002/mds.25541
– ident: e_1_2_8_60_1
  doi: 10.1212/WNL.0b013e3181f39d0e
– volume: 19
  start-page: 19
  year: 2014
  ident: e_1_2_8_29_1
  article-title: Neuropsychological profiles and their correlation to motor symptoms in newly diagnosed Parkinson disease patients with mild cognitive impairment
  publication-title: Neurology Asia
– ident: e_1_2_8_16_1
  doi: 10.1159/000350032
– ident: e_1_2_8_62_1
  doi: 10.3389/fnhum.2016.00356
– ident: e_1_2_8_19_1
  doi: 10.1002/mds.26643
– ident: e_1_2_8_48_1
  doi: 10.1002/mds.25982
– ident: e_1_2_8_10_1
  doi: 10.1176/appi.neuropsych.15090221
– ident: e_1_2_8_12_1
  doi: 10.1016/j.parkreldis.2014.01.009
– ident: e_1_2_8_51_1
  doi: 10.1111/pcn.12819
– ident: e_1_2_8_11_1
  doi: 10.1016/j.parkreldis.2015.08.024
– ident: e_1_2_8_35_1
  doi: 10.1177/0891988712464823
– ident: e_1_2_8_15_1
  doi: 10.1016/j.jocn.2014.11.030
– ident: e_1_2_8_4_1
  doi: 10.1212/01.wnl.0000180516.69442.95
– ident: e_1_2_8_68_1
  doi: 10.1212/01.wnl.0000230572.07791.22
– ident: e_1_2_8_61_1
  doi: 10.1002/brb3.719
– ident: e_1_2_8_41_1
  doi: 10.1016/j.jns.2014.09.049
– ident: e_1_2_8_66_1
  doi: 10.1016/j.parkreldis.2015.02.015
– ident: e_1_2_8_5_1
  doi: 10.1007/s00415-018-8800-4
– ident: e_1_2_8_31_1
  doi: 10.1002/gps.4261
– ident: e_1_2_8_55_1
  doi: 10.1111/ene.13467
– ident: e_1_2_8_47_1
  doi: 10.1177/1533317517698794
– ident: e_1_2_8_40_1
  doi: 10.1002/mds.25426
– ident: e_1_2_8_22_1
  doi: 10.1037/1082-989X.11.2.193
– ident: e_1_2_8_7_1
  doi: 10.1111/j.1365-2796.2004.01388.x
– ident: e_1_2_8_42_1
  doi: 10.1001/jamaneurol.2013.2110
– ident: e_1_2_8_54_1
  doi: 10.1371/journal.pone.0152716
SSID ssj0011516
Score 2.6652524
SecondaryResourceType review_article
Snippet Mild cognitive impairment associated with Parkinson's disease (PD) is a risk factor for the development of dementia. Despite the importance of early...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 45
SubjectTerms Age Factors
Clinical aspects
Cognitive ability
cognitive decline
Cognitive Dysfunction - complications
Cognitive Dysfunction - epidemiology
Confidence intervals
Dementia disorders
Emotional behavior
Gait
Humans
Levodopa
Meta-analysis
Mild cognitive impairment
Movement disorders
Neurodegenerative diseases
Neuropsychological Tests
nonmotor symptoms
Parkinson Disease - complications
Parkinson Disease - enzymology
Parkinson's disease
Prevalence
Quality of life
Risk Factors
Title Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta‐analysis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.27902
https://www.ncbi.nlm.nih.gov/pubmed/31743500
https://www.proquest.com/docview/2342957385
https://www.proquest.com/docview/2316429491
Volume 35
WOSCitedRecordID wos000497131100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1531-8257
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011516
  issn: 0885-3185
  databaseCode: DRFUL
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fa9swED_SdJS9dOvabdm6oI5C--LGlmxL6p7K2tCHNpS1gbwZWX8gkDgjTvbcj7DPuE8ySf5TQjcY7M2gMyckne9O59_vAI5prjhOpQ4US8MgpoYHTEsS8EQb5b20Er7ZBB2N2GTC7zrwpcHCVPwQ7YWbswz_vXYGLvJy8EQaOlflGabcEUluY3tuky5sX34bjm_aIoJ1ZmkVRCYeJNwQC4V40L686Y6exZibIav3OcNX_zXb17Bbh5roojobe9DRxRvYua2L6ftgHH2T8KAjJAqFGpAkEh5-WaKFQfPpzA40vxghh6mcLt2FIpoWyCGmPXjspER1oeccXaC5Xolfjz9FTXdyAOPh1cPX66BuuxBIVxIOhJbMUd5QSbXJBWfMmFiTJMrjnERaRUowJsM85SIiidEJjg1PNSeCUCEMIW-hWywK_R5QRJhRxEQpMzYTS3FOrQKuMTeKpkqKHpw2q5_JmpPctcaYZRWbMs7sumV-3XrwuRX9XhFx_EnosNnCrLZFO0Ksz00ca08Pjtpha0WuNCIKvVg7GZs2Yh7zqAfvqq1vtRCXtCVhaCfrd_jv6rPby3v_8OHfRT_CS-xSeH-rcwjd1XKtP8EL-WM1LZd92KIT1q8P9m_tCPvB
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS-QwFD6Iivri_TJedrMi7L5U26RtEvFFdAdlZwZxFXwraS4w4HRkZvTZn-Bv9JeYpBcRd2Fh3wo5JSE5p-fW7wvAAc0Vx6nUgWJpGMTU8IBpSQKeaKO8l1bCXzZBez12d8evpuCkxsKU_BBNwc1Zhv9eOwN3Bemjd9bQgRofYsodk-RMbNXI6vfM-XX7ttN0Eaw3S8soMvEo4ZpZKMRHzcsf_dGnIPNjzOqdTnvp_5a7DItVsIlOS-1YgSldrMJct2qnr4FxBE7Cw46QKBSqYZJIeADmGA0NGvTv7UD9kxFyqMr-yJUUUb9ADjPt4WPfx6hq9RyjUzTQE_H6_CIqwpN1uG3_vDm7CKqLFwLpmsKB0JI50hsqqTa54IwZE2uSRHmck0irSAnGZJinXEQkMTrBseGp5kQQKoQhZAOmi2GhtwBFhBlFTJQyY3OxFOfUTsA15kbRVEnRgh_19meyYiV3l2PcZyWfMs7svmV-31qw34g-lFQcfxLarc8wq6zRjhDrdRPH29OCb82wtSPXHBGFHj46GZs4Yh7zqAWb5dk3sxCXtiVhaBfrj_jv02fd89_-YfvfRb_C_MVNt5N1Lnu_dmABu4Te13h2YXoyetR7MCufJv3x6Eul328Lnf7J
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7CJoRe8ugrTpNULYX24saWbEsKuSzZmJZultB2YW9G1gMWst6wu8k5P6G_sb-kkvwIoSkEejNojIRG45nR-PsG4AMtFceZ1KFiWRQm1PCQaUlCnmqjvJdWwjeboKMRm0z45RqctliYmh-iu3BzluG_187A9bUyx_esoTO1_Iwpd0yS64lrItOD9cH3fDzsqgjWm2V1FJl6lHDLLBTh4-7lh_7oryDzYczqnU6-_X_L3YGtJthE_fp07MKarp7D5kVTTn8BxhE4CQ87QqJSqIVJIuEBmEs0N2g2vbID7U9GyKEqpwt3pYimFXKYaQ8f-7hETannBPXRTK_E77tfoiE8eQnj_Pzn2ZewabwQSlcUDoWWzJHeUEm1KQVnzJhEkzQuk5LEWsVKMCajMuMiJqnRKU4MzzQnglAhDCGvoFfNK70HKCbMKGLijBmbi2W4pHYCrjE3imZKigA-tdtfyIaV3DXHuCpqPmVc2H0r_L4F8L4Tva6pOB4TOmh1WDTWaEeI9bqp4-0J4F03bO3IFUdEpec3TsYmjpgnPA7gda37bhbi0rY0iuxivYr_PX1xMfjhH_afLvoWNi8HeTH8Ovr2Bp5hl8_7K54D6K0WN_oQNuTtarpcHDXH-w-ZXP5E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Clinical+Aspects+of+Mild+Cognitive+Impairment+in+Parkinson%27s+Disease%3A+A+Meta%E2%80%90Analysis&rft.jtitle=Movement+disorders&rft.au=Baiano%2C+Chiara&rft.au=Barone%2C+Paolo&rft.au=Trojano%2C+Luigi&rft.au=Santangelo%2C+Gabriella&rft.date=2020-01-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=35&rft.issue=1&rft.spage=45&rft.epage=54&rft_id=info:doi/10.1002%2Fmds.27902&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon